TP53 and breast cancer: Notably, the suppression of BMF expression by mutant p53-R273H in breast cancer cells is independent of direct promoter binding, as no endogenous p53-R273H was detected at the BMF promoter by chromatin immunoprecipitation assay (Supplementary Figure 3).